Abstract: Gene expression data, in particular gene expression profiles, are created and used in the identification, monitoring and treatment of disease and characterization of biological conditions. Profile data sets are derived from subject samples and include quantitative substantially repeatable measures of a distinct amount of RNA or protein constituent in a panel selected to enable evaluation of a biological condition. Such profile data sets may be used to provide an index indicative of the biological state of a subject, which may be compared to a normative value of the index determined with respect to a relevant population of subjects.
Type:
Grant
Filed:
June 22, 2005
Date of Patent:
June 7, 2011
Assignee:
Source Precision Medicine, Inc.
Inventors:
Michael Bevilacqua, John C. Cheronis, Victor Tryon, Danute Bankaitis-Davis
Abstract: A method is provided in various embodiments for determining a profile data set for a subject with rheumatoid arthritis or inflammatory conditions related to rheumatoid arthritis based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 2 constituents from Tables 1-2 and Tables 4-10. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.
Type:
Grant
Filed:
September 27, 2006
Date of Patent:
May 3, 2011
Assignee:
Source Precision Medicine, Inc.
Inventors:
Danute Bankaitis-Davis, Kathy Storm, Lisa Siconolfi, David B. Trollinger, Karl Wassmann
Abstract: Rodent gene expression data, in particular, gene expression profiles, are created and used to predict the efficacy of therapeutic agents on human biological conditions. Gene Profile data sets are derived from rodent subject samples and include quantitative, substantially repeatable measures of a distinct amount of RNA or protein constituent(s) in a signature panel selected such that measurement of the constituent(s) enables measurement of a biological condition of interest in both human and rodent subjects. Such profile data sets may be used to predict the therapeutic efficacy of a therapeutic agent in humans.
Type:
Application
Filed:
July 29, 2010
Publication date:
April 21, 2011
Applicant:
Source Precision Medicine, Inc.
Inventors:
Michael Bevilacqua, Victor Tryon, John Cheronis, Danute Bankaitis-Davis, Kathleen Storm, Karl Wassmann
Abstract: A method for quantitatively assaying one or more target molecules in a sample uses a nucleic acid aptamer that is specific for each target molecule. A quantitative replicative procedure is used to determine a quantity of aptamer specific for each molecule.
Abstract: Gene expression data, in particular gene expression profiles, are created and used in the identification, monitoring and treatment of disease and characterization of biological conditions. Profile data sets are derived from subject samples and include quantitative substantially repeatable measures of a distinct amount of RNA or protein constituent in a panel selected to enable evaluation of a biological condition. Such profile data sets may be used to provide an index indicative of the biological state of a subject, which may be compared to a normative value of the index determined with respect to a relevant population of subjects.
Type:
Grant
Filed:
November 8, 2002
Date of Patent:
November 15, 2005
Assignee:
Source Precision Medicine, Inc.
Inventors:
Michael P. Bevilacqua, John C. Cheronis, Victor Tryon, Danute M. Bankaitis-Davis
Abstract: Gene expression data, in particular gene expression profiles, are created and used in the identification, monitoring and treatment of disease and characterization of biological conditions. Profile data sets are derived from subject samples and include quantitative substantially repeatable measures of a distinct amount of RNA or protein constituent in a panel selected to enable evaluation of a biological condition. Such profile data sets may be used to provide an index indicative of the biological state of a subject, which may be compared to a normative value of the index determined with respect to a relevant population of subjects.
Type:
Grant
Filed:
November 8, 2002
Date of Patent:
November 1, 2005
Assignee:
Source Precision Medicine, Inc.
Inventors:
Michael Bevilacqua, Danute M. Bankaitis-Davis, John C. Cheronis, Victor Tryon
Abstract: Methods are provided for evaluating a biological condition of a subject using a calibrated profile data set derived from a data set having a plurality of members, each member being a quantitative measure of the amount of a subject's RNA or protein as distinct constituents in a panel of constituents. The biological condition may be a naturally occurring physiological state or may be responsive to treatment of the subject with one or more agents. Calibrated profile data sets may be used as a descriptive record for an agent.
Type:
Grant
Filed:
March 29, 2001
Date of Patent:
February 17, 2004
Assignee:
Source Precision Medicine, Inc.
Inventors:
Michael P. Bevilacqua, Danute M. Bankaitis-Davis, John C. Cheronis, Victor Tryon